Mosaic Neurofibromatosis Type 1 C5782097
A milder genetic disorder causing café-au-lait spots and skin changes, with symptoms that may vary depending on which cells carry the gene change. Regular monitoring and supportive care help manage the condition.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Optic pathway glioma
Café-au-lait macules
(neurologic)Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Neurofibromas
(neurologic)Learning disability
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Regular Tumor and Complication Surveillance
Comprehensive annual monitoring including dermatological exams, ophthalmological assessments, neurological evaluation, and imaging studies to detect new neurofibromas, optic gliomas, or other complications.
Symptomatic Medication Management
Pharmacological treatment for associated symptoms such as pain, seizures, ADHD, or learning disabilities with appropriate medications tailored to individual presentation.
Additional treatment options
Surgical Tumor Removal
Surgical excision of symptomatic, disfiguring, or functionally impairing neurofibromas, with consideration for reconstructive procedures when needed.
surgicalPsychosocial Support and Counseling
Psychological support addressing body image concerns, social challenges, learning difficulties, and coping with a chronic genetic condition affecting appearance.
psychologicalSun Protection and Trigger Avoidance
Strict sun protection and avoidance of smoking, which may exacerbate tumor growth, along with general healthy lifestyle practices.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Mosaic Neurofibromatosis Type 1 C5782097?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Hirbe AC, Gutmann DH. Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol. 2022.
Ruggieri M, Huson SM. The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology. 2021.
Kehrer-Sawatzki H, Mautner VF, Cooper DN. Germline and somatic NF1 gene mutations in mosaic neurofibromatosis type 1. J Invest Dermatol. 2020.
Stewart DR, Korf BR, Nathanson KL, Messiaen LM, Yohay K. Care of adults with neurofibromatosis type 1: a clinical practice resource. Genet Med. 2023.
Medication Comparisons
Compare medications used to treat Mosaic Neurofibromatosis Type 1 C5782097. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy